{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:55:45Z","timestamp":1760982945093},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"764","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1989,6,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Visual hallucinations are a well recognized unwanted effect of treatment with levodopa. Although many individual cases have been reported, there has only been one review previously published about this finding, and this did not discriminate age groups. We present five cases and briefly review the literature. It is important to enquire specifically about visual hallucinations in patients on levodopa therapy at follow up, as this otherwise potentially reversible side effect may be overlooked.<\/jats:p>","DOI":"10.1136\/pgmj.65.764.358","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:05:27Z","timestamp":1230584727000},"page":"358-361","source":"Crossref","is-referenced-by-count":29,"title":["Visual hallucinations in the elderly associated with the use of levodopa"],"prefix":"10.1093","volume":"65","author":[{"given":"A K","family":"Banerjee","sequence":"first","affiliation":[{"name":"Division of Cell Biology, M.R.C. Clinical Research Centre, Northwick Park Hospital , Watford Road, Harrow, Middlesex HA 3UJ , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P G","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Savidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1989,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/jnnp.34.5.502","article-title":"Psychiatric aspects in parkinsonism treated with L-Dopa","volume":"34","author":"Damasio, A.R.; Antunes, J.L.; Macedo, C.","year":"1971","unstructured":"Damasio, A.R., Antunes, J.L. & Macedo, C. Psychiatric aspects in parkinsonism treated with L-Dopa. J Neurol Neurosurg Psychiatry 1971, 34: 502-507.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"271 -277","key":"ref_2","article-title":"Psychiatric complications of Levodopa therapy of Parkinson's Disease","volume":"40","author":"Nausieda, P.A.; Glantz, R.; Weber, B.; Baum, R.; Klawans, H.L.","unstructured":"Nausieda, P.A., Glantz, R., Weber, B., Baum, R. & Klawans, H.L. Psychiatric complications of Levodopa therapy of Parkinson's Disease. Adv Neurol 1984, 40: 271 -277.","journal-title":"Adv Neurol"},{"issue":"40","key":"ref_3","first-page":"259","article-title":"Mental disorders in Parkinson's disease after treatment with L-Dopa","volume":"1984","author":"Rondot, P.; de Recondo, J.; Coignet, A.; Ziegler, M.","unstructured":"Rondot, P., de Recondo, J., Coignet, A. & Ziegler, M. Mental disorders in Parkinson's disease after treatment with L-Dopa. Adv Neurol 1984, 40: 259-269.","journal-title":"Adv Neurol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0140-6736(70)92535-3","article-title":"Mental symptoms in parkinsonian patients treated with L-Dopa","volume":"ii:","author":"Jenkins, R.B.; Groh, R.H.","year":"1970","unstructured":"Jenkins, R.B. & Groh, R.H. Mental symptoms in parkinsonian patients treated with L-Dopa. Lancet 1970, ii: 177-179.","journal-title":"Lancet"},{"key":"ref_5","first-page":"1231","article-title":"Effects of L-Dopa in patients with dementia","volume":"i:","author":"Sachs, O.W.; Messeloff, C.; Schwartz, W.; Goldfarb, A.; Kohl, M.","year":"1970","unstructured":"Sachs, O.W., Messeloff, C., Schwartz, W., Goldfarb, A. & Kohl, M. Effects of L-Dopa in patients with dementia. Lancet 1970, i: 1231.","journal-title":"Lancet"},{"issue":"305-3","key":"ref_6","first-page":"10","article-title":"Mental symptoms in Parkinson's disease during chronic treatment with levodopa","volume":"26","author":"Sweet, R.D.; Fletcher, H.; Feigenson, J.S.; Loranger, A.W.; Goodell, H.","year":"1976","unstructured":"Sweet, R.D., Fletcher, H., Feigenson, J.S., Loranger, A.W. & Goodell, H. Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 1976, 26: 305-3 10.","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01579073","article-title":"Dream phenomena induced by chronic levodopa therapy","volume":"43","author":"Sharf, A.; Moskovitz, Ch; Lupton, M.D.; Klawans, H.L.","year":"1978","unstructured":"Sharf, A., Moskovitz, Ch., Lupton, M.D. & Klawans, H.L. Dream phenomena induced by chronic levodopa therapy. Neural Transmission 1978, 43: 143-151.","journal-title":"Neural Transmission"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/ajp.135.6.669","article-title":"Levodopainduced psychosis: a kindling phenomenon","volume":"135","author":"Moskovitz, Ch; Moses, H.; Klawans, H.L.","year":"1978","unstructured":"Moskovitz, Ch., Moses, H. & Klawans, H.L. Levodopainduced psychosis: a kindling phenomenon. Am J Psychiatry 1978, 135: 669-675.","journal-title":"Am J Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.2.5909.1","article-title":"Mental changes in parkinsonism","volume":"2","author":"Editorial","year":"1974","unstructured":"Editorial. Mental changes in parkinsonism. Br Med J 1974, 2: 1C.","journal-title":"Br Med J"},{"key":"ref_10","first-page":"39","article-title":"Inappropriate prescribing in the elderly","volume":"21","author":"Adams, K.R.H.; Al-Hamouz, S.; Edmund, E.; Tallis, R.C.; Vellodi, C.; Lye, M.","year":"1987","unstructured":"Adams, K.R.H., Al-Hamouz, S., Edmund, E., Tallis, R.C., Vellodi, C. & Lye, M. Inappropriate prescribing in the elderly. J R Coll Physicians Lond 1987, 21: 39-41.","journal-title":"J R Coll Physicians Lond"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.30.12.1257","article-title":"Drug holiday and management of Parkinson's disease","volume":"30","author":"Weiner, W.J.; Koller, W.C.; Perlik, St; Nausieda, P.A.; Klawans, H.L.","year":"1980","unstructured":"Weiner, W.J., Koller, W.C., Perlik, St., Nausieda, P.A. & Klawans, H.L. Drug holiday and management of Parkinson's disease. Neurology 1980, 30: 1257-1261.","journal-title":"Neurology"},{"issue":"221","key":"ref_12","first-page":"1054","article-title":"Levodopa and hallucinations","volume":"1972","author":"Weinman, R.L.","unstructured":"Weinman, R.L. Levodopa and hallucinations. JAMA 1972, 221: 1054.","journal-title":"JAMA"},{"key":"ref_13","first-page":"1560","article-title":"Drug-induced psychiatric disorders","volume":"1","author":"Davison, K.","year":"1983","unstructured":"Davison, K. Drug-induced psychiatric disorders. Med let 1983, 1: 1560-1563.","journal-title":"Med let"},{"key":"ref_14","first-page":"987","article-title":"Bromocriptine in parkinsonism","volume":"ii:","author":"Debono, A.; Donaldson, I.; Marsden, C.D.","year":"1975","unstructured":"Debono, A., Donaldson, I., Marsden, C.D. Bromocriptine in parkinsonism. Lancet 1975, ii: 987-988.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archneur.1978.00500320023005","article-title":"Bromocriptine in parkinsonism","volume":"35","author":"Lees, A.J.; Haddad, S.; Shaw, K.M.","year":"1978","unstructured":"Lees, A.J., Haddad, S. & Shaw, K.M. Bromocriptine in parkinsonism. Arch Neurol 1978, 35: 503-505.","journal-title":"Arch Neurol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000212220","article-title":"L-Tryptophan administration in L-dopa induced hallucinations in elderly parkinsonian patients","volume":"23","author":"Raby, J.M.; Vardi, J.; Askenazi, J.J.; Strufler, M.","year":"1977","unstructured":"Raby, J.M., Vardi, J., Askenazi, J.J. & Strufler, M. L-Tryptophan administration in L-dopa induced hallucinations in elderly parkinsonian patients. Gerontology 1977, 23: 438-444.","journal-title":"Gerontology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.31.4_Part_2.473","article-title":"Complications of chronic levodopa therapy: long term-efficacy of drug holiday","volume":"31","author":"Koller, W.C.; Weiner, W.J.; Perlik, St; Nausieda, P.A.; Goetz, Chr G.; Klawans, H.L.","year":"1981","unstructured":"Koller, W.C., Weiner, W.J., Perlik, St., Nausieda, P.A., Goetz, Chr. G. & Klawans, H.L. Complications of chronic levodopa therapy: long term-efficacy of drug holiday. Neurology 1981, 31: 473-476.","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002826-197800030-00010","volume":"3","author":"Calne, D.B.In","unstructured":"Calne, D.B. In: Klawans, H.L. (ed.) Clinical Neuropharmacology, vol. 3. Springer Verlag, Berlin, pp. 153-166.","journal-title":"Clinical Neuropharmacology"},{"issue":"37","key":"ref_19","first-page":"427","article-title":"Attempted use of haloperidol in the treatment of L-Dopa induced dysdinesia","volume":"1974","author":"Klawans, H.L.; Weiner, W.J.","unstructured":"Klawans, H.L. & Weiner, W.J. Attempted use of haloperidol in the treatment of L-Dopa induced dysdinesia. J Neurol Neurosurg Psychiatry 1974, 37: 427-430.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref_20","article-title":"Drugs for Parkinson's disease","volume":"986","author":"Caird, F.I.; Williamson, J.","year":"1978","unstructured":"Caird, F.I. & Williamson, J. Drugs for Parkinson's disease. Lancet 1978, i: 986.","journal-title":"Lancet"},{"key":"ref_21","first-page":"1","article-title":"An Introduction to the Psychiatry of Old Age","author":"Pitt, B.Psychogeriatrics","year":"Y.,","unstructured":"Pitt, B. Psychogeriatrics. An Introduction to the Psychiatry of Old Age. Churchill Livingstone, Edinburgh, London, N.Y., pp. 1-3."}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/65\/764\/358\/50076604\/postgradmedj-65-358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/65\/764\/358\/50076604\/postgradmedj-65-358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T10:39:28Z","timestamp":1683196768000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/65\/764\/358\/7044563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6,1]]},"references-count":21,"journal-issue":{"issue":"764","published-online":{"date-parts":[[1989,6,1]]},"published-print":{"date-parts":[[1989,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.65.764.358","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1989,6]]},"published":{"date-parts":[[1989,6,1]]}}}